Home › Targets › ITK

ITK (2 companies · 8 programs)

Companies with an active program directed at ITK.

Corvus Pharmaceuticals, Inc. CRVS

soquelitinib — Peripheral T Cell Lymphoma Phase 3
soquelitinib — Atopic Dermatitis Phase 2
soquelitinib — Autoimmune Lymphoproliferative Syndrome Phase 2
soquelitinib — Hidradenitis Suppurativa Phase 1
soquelitinib — Asthma Preclinical

Aclaris Therapeutics ACRS

modzatinib — Atopic Dermatitis Phase 2
ATI-9494 Preclinical
modzatinib — Lichen Planus Phase 1